Biosimilars and drug development in allergic and immunologic diseases

Sergio Bonini; Matteo Bonini

doi:10.1016/j.jaci.2017.03.008

Biosimilars and drug development in allergic and immunologic diseases

Sergio Bonini
, Matteo Bonini

Università Cattolica del Sacro Cuore

University of Campania Luigi Vanvitelli

Risultato della ricerca: Contributo in rivista › Articolo

1 Citazioni (Scopus)

Abstract

...

Lingua originale	Inglese
pagine (da-a)	1461-1464
Numero di pagine	4
Rivista	Journal of Allergy and Clinical Immunology
Volume	139
DOI	https://doi.org/10.1016/j.jaci.2017.03.008
Stato di pubblicazione	Pubblicato - 2017

Keywords

Allergic
Animals
Anti-Allergic Agents
Antirheumatic Agents
Biological Products
Biosimilar Pharmaceuticals
Drug Development
Drugs, Generic
Europe
Humans
Hypersensitivity
Immune System Diseases
Immunology
Immunology and Allergy
United States
biologics

Accesso al documento

10.1016/j.jaci.2017.03.008

Altri file e collegamenti

Cita questo

@article{17d84d2e5da74284b9006b6dfec36125,

title = "Biosimilars and drug development in allergic and immunologic diseases",

abstract = "...",

keywords = "Allergic, Animals, Anti-Allergic Agents, Antirheumatic Agents, Biological Products, Biosimilar Pharmaceuticals, Drug Development, Drugs, Generic, Europe, Humans, Hypersensitivity, Immune System Diseases, Immunology, Immunology and Allergy, United States, biologics, Allergic, Animals, Anti-Allergic Agents, Antirheumatic Agents, Biological Products, Biosimilar Pharmaceuticals, Drug Development, Drugs, Generic, Europe, Humans, Hypersensitivity, Immune System Diseases, Immunology, Immunology and Allergy, United States, biologics",

author = "Sergio Bonini and Matteo Bonini",

year = "2017",

doi = "10.1016/j.jaci.2017.03.008",

language = "English",

volume = "139",

pages = "1461--1464",

journal = "Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Biosimilars and drug development in allergic and immunologic diseases

AU - Bonini, Sergio

AU - Bonini, Matteo

PY - 2017

Y1 - 2017

N2 - ...

AB - ...

KW - Allergic

KW - Animals

KW - Anti-Allergic Agents

KW - Antirheumatic Agents

KW - Biological Products

KW - Biosimilar Pharmaceuticals

KW - Drug Development

KW - Drugs, Generic

KW - Europe

KW - Humans

KW - Hypersensitivity

KW - Immune System Diseases

KW - Immunology

KW - Immunology and Allergy

KW - United States

KW - biologics

KW - Allergic

KW - Animals

KW - Anti-Allergic Agents

KW - Antirheumatic Agents

KW - Biological Products

KW - Biosimilar Pharmaceuticals

KW - Drug Development

KW - Drugs, Generic

KW - Europe

KW - Humans

KW - Hypersensitivity

KW - Immune System Diseases

KW - Immunology

KW - Immunology and Allergy

KW - United States

KW - biologics

UR - http://hdl.handle.net/10807/134646

UR - http://www.elsevier.com/inca/publications/store/6/2/3/3/6/8/index.htt

U2 - 10.1016/j.jaci.2017.03.008

DO - 10.1016/j.jaci.2017.03.008

M3 - Article

SN - 0091-6749

VL - 139

SP - 1461

EP - 1464

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

ER -

Biosimilars and drug development in allergic and immunologic diseases

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo